Advertisement

VAPO

Vapotherm, Inc.

Healthcare

Set alert

Price alert · VAPO

All alert types
2.17 0.00 0.00%
As of Sep 19, 2024
2.17 Day range 2.17

52-week range unavailable

Open
2.17
Prev close
2.17
Mkt cap
6.94M
Vol
28.04K
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
2.17
High
2.17
Forward P/E
-0.39
Beta
-1.19
Short ratio
12.93
Inst. own
48.13%
Dividend
0.00
Ex-div date
Earnings
Dec 25, 2024
50-d avg
2.00
200-d avg
3.28
1y target
1.00

2Y chart

Chart tools
Interval
VAPO two-year price chart0.706.4412.217.923.7Sep 22Feb 23Jul 23Nov 23Apr 24Sep 24

Key statistics

Market cap
6.94M
Enterprise value
102.82M
Trailing P/E
0.00
Forward P/E
-0.39
PEG ratio
-0.01
Price / sales
0.10
Price / book
0.00
EPS (TTM)
-14.33
Beta
-1.19
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-102.73%
Revenue (TTM)
67.60M
Revenue growth
12.00%
Free cash flow
-21.57M
Total cash
14.42M
Total debt
111.10M
Return on equity
0.00%
Shares outstanding
6.14M
Short % of float
10.20%
50-day average
2.00
200-day average
3.28

Analyst view

Consensus: hold

Hold
Price target (mean) 1.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
  • Strong buy4
  • Buy0
  • Hold0
  • Sell0
  • Strong sell0

Next earnings

Dec 25, 2024

Expected Dec 25, 2024. Consensus EPS estimate -1.63.

Earnings history

Financials — quick view

All financials
VAPO Revenue — quarterly 15.17M
2019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 2023
VAPO Net income — quarterly -15.13M
2019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 2023
VAPO EPS — quarterly -2.38
2019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 2023

Earnings

VAPO recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Dec 25, 2024Sep 1, 20240.00———
Aug 12, 2024Jun 1, 20240.00-1.76——
May 9, 2024Mar 1, 20240.00-2.31——
Feb 22, 2024Dec 1, 20230.00-1.60——
Nov 8, 2023Sep 1, 2023-2.20-2.26-0.06-2.73%
Aug 8, 2023Jun 1, 2023-3.04-2.32+0.72+23.68%

About Vapotherm, Inc.

Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers precision flow systems, such as HVT 2.0, Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that deliver heated, humidified, and oxygenated air at a high velocity to treat patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor, which provides compressed air necessary to run the precision flow systems; aerosol aeroneb adaptor to facilitate delivery of ultrasonic aerosolized medication; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol medication; and tracheostomy adaptors. In addition, Vapotherm, Inc. offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Modules, which helps clinicians maintain oxygen levels within a target range. The company sells its products to hospitals. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.

Sector
Healthcare
Industry
Medical Devices
Country
United States

News

Your note

Sign in to keep a note on VAPO — it syncs with the Stock Master app.

Insider holders

VAPO insider holders
InsiderRelationLatest transactionDateShares held
ARMY JOSEPH FChief Executive OfficerPurchaseSep 7, 2023432,783
ARNERICH ANTHONY LDirectorStock Award(Grant)Dec 28, 2023214,618
BERRY LANCE ADirectorStock Award(Grant)Jul 25, 2023155,887
KNOWLES LORI LYNNDirectorStock Award(Grant)Dec 28, 202310,237
LANDRY JOHNChief Financial OfficerStock Award(Grant)Oct 1, 202370,411
LAWRENCE BRIANChief Technology OfficerStock Award(Grant)Oct 1, 202360,188

Institution ownership

VAPO institution ownership
Holder% heldSharesValueReported
Crow's Nest Holdings LP1.14%561,0022.00MJun 29, 2023
Armistice Capital, LLC0.96%471,2501.68MJun 29, 2023
Millennium Management Llc0.72%354,3551.26MJun 29, 2023
Taylor Frigon Capital Management LLC0.57%279,896996.43KJun 29, 2023
Vanguard Group Inc0.32%154,656550.58KJun 29, 2023
Tejara Capital Ltd0.22%107,467382.58KJun 29, 2023

Fund ownership

VAPO fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund0.22%110,297392.66KJun 29, 2023
PFS Funds-Taylor Frigon Core Growth Fund0.10%49,359156.96KAug 30, 2023
Vanguard Extended Market Index Fund0.08%39,848141.86KJun 29, 2023
Bridgeway Funds Inc-Ultra Small Company Market Fund0.04%18,68866.53KJun 29, 2023
Fidelity Extended Market Index Fund0.03%14,85872.51KMay 30, 2023
Fidelity Series Total Market Index Fund0.01%3,87018.89KMay 30, 2023
Advertisement